In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer

Experimental and Molecular Pathology

Volumn 82, Issue 3, 2007, Pages 292-297

  Seifert, Hans Helge ^a   Schmiemann, Viola ^a   Mueller, Mirko ^a   Kazimirek, Marietta ^a   Onofre, Fabiana ^a   Neuhausen, Anne ^a   Florl, Andrea R ^a   Ackermann, Rolf ^a   Boecking, Alfred ^a   Schulz, Wolfgang A ^a   Grote, Hans Juergen ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

5 methyl cytosine; Bladder cancer; Cytological detection; Hypomethylation

Indexed keywords

5 METHYLCYTOSINE; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CARCINOMA CELL; CELL STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; SOUTHERN BLOTTING; URINARY TRACT DISEASE; URINE CYTOLOGY;

5-METHYLCYTOSINE; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BLOTTING, SOUTHERN; CYTODIAGNOSIS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 34247599838     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.08.002     Document Type: Article

References (18)

1. Catto J.W., Azzouzi A.R., Rehman I., Feeley K.M., Cross S.S., Amira N., Fromont G., Sibony M., Cussenot O., Meuth M., and Hamdy F.C. Promotor hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J. Clin. Oncol. 23 (2005) 2903-2910
2. Chan M.W.Y., Chan L.W., Tang N.L.S., Tong J.H.M., Lo K.W., Lee T.L., Cheung H.Y., Wong W.S., Chan P.S.F., Lai F.M.M., and To K.F. Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients. Clin. Cancer Res. 8 (2003) 464-470
3. De Capoa A., Grappelli C., Febbo F.R., Spano A., Niveleau A., Cafolla A., Cordone I., and Foa A. DNA demethylation is directly related to tumor progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol. Rep. 10 (2003) 545-549
4. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 21 (2002) 5400-5413
5. Florl A.R., Loewer R., Schmitz-Dräger B.J., and Schulz W.A. DNA methylation and expression of L1 LINE and HERV-K provirus sequences in urothelial and renal cell carcinoma. Br. J. Cancer 80 (1999) 1312-1321
6. Florl A.R., Franke K.H., Niederacher D., Gerharz C.D., Seifert H.H., and Schulz W.A. DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder. Lab. Invest. 80 (2000) 1513-1522
7. Hoffmann M.J., and Schulz W.A. Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell. Biol. 83 (2005) 296-321
8. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev., Genet. 3 (2002) 415-428
9. Jones T.D., Wang M., Eble J.N., MacLennan G.T., Lopez-Beltran A., Zhang S., Cocco A., and Cheng L. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin. Cancer Res. 11 (2005) 6512-6519
10. Jürgens B., Schmitz-Dräger B.J., and Schulz W.A. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res. 56 (1999) 5698-5703
11. Kimura F., Seifert H.H., Florl A.R., Santourlidis S., Steinhoff C., Swiatkowski S., Mahotka C., Gerharz C.D., and Schulz W.A. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int. J. Cancer 104 (2003) 568-578
12. Markl I.D.C., Cheng J., Liang G., Shibata D., Laird P.W., and Jones P.A. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res. 61 (2001) 5884
13. Maruyama R., Toyooka S., Toyooka K.O., Harada K., Virmani A.K., Zochbauer-Muller S., Farinas A.J., Vakar-Lopez F., Minna J.D., Sagalowsky A., Czerniak B., and Gazdar A.F. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 61 (2001) 8659-8663
14. Piyathilake C.J., Henao O., Frost A.R., Macaluso M., Bell W.C., Johanning G.L., Heimburger D.C., Nivelau A., and Grizzle W.E. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes & Control 14 (2003) 37-42
15. Salem C., Liang G., Tsai Y.C., Coulter J., Knowles M.A., Feng A.C., Groshen S., Nichols P.W., and Jones P.A. Progressive increases in de novo methylation of CpG island in bladder cancer. Cancer Res. 60 (2000) 2473-2476
16. Sobin, L.H., Wittekind, C.H., 1997. TNM classification of malignant tumours, UICC. New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss 5th Edition, 1997.
17. Stoehr R., Zietz S., Burger M., Filbeck T., Denzinger S., Obermann E.C., Hammerschmied C., Wieland W.F., Knuechel R., and Hartmann A. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur. Urol. 47 (2005) 58-63
18. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., Ehrlich M., and Laird P.W. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 33 (2005) 6823-6836